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Chronic respiratory disease affects one billion people world-
wide and is a leading cause of death.1 Most forms of the disease 
are noncommunicable, such as chronic obstructive pulmonary 
disease (COPD), asthma, chronic bronchitis, occupational 
lung disease and pulmonary hypertension. Currently, the 
associated morbidity and mortality principally occur in low- 
and middle-income countries, where the disease burden is 
expected to rise as rapid economic gains lead to increases 
in longevity, industrialization and tobacco consumption.1–3 
In addition to its impact on individuals, this epidemiologi-
cal transition has substantial direct and indirect economic 
implications.4
Urbanization has been associated with noncommuni-
cable diseases, including chronic respiratory disease,5,6 and is 
expected to increase as virtually all future population growth 
will be concentrated in urban areas.7 There are particular 
concerns about sub-Saharan Africa, where rapid urbanization 
and population growth are coupled with an inadequate health 
infrastructure and poor urban planning.7 Little is known about 
the association between urbanization and the shifting burden 
of chronic respiratory disease in low- and middle-income 
countries, particularly those in sub-Saharan Africa. Previous 
studies have examined the prevalence of COPD in either rural 
or urban settings,8–10 but none has investigated how the pattern 
of chronic respiratory disease varies across different residential 
settings, with the aim of evaluating the impact of the urban 
environment. Moreover, understanding of the population at-
tributable risk (PAR) for different chronic respiratory diseases 
in African populations is limited. Nevertheless, COPD has 
been closely linked to household air pollution in rural areas 
in low- and middle-income countries and the disease burden 
is expected to increase in urban areas with the growing preva-
lence of tobacco smoking.2
The primary aim of this study was to examine variations 
in the prevalence of different chronic respiratory diseases and 
their attributable risk factors between urban and rural Uganda. 
In both settings, we assessed the respiratory symptoms and 
functional status of individuals with obstructive lung disease.
Methods
We conducted a cross-sectional, population-based cohort 
study in an urban centre and a rural district in Uganda. The 
urban sample was drawn from Kampala, the capital city, 
which had a population of 1.5 million in an estimated 416 070 
households in 2014.11 The rural sample was drawn from Na-
kaseke, a health district covering 43 167 households with an 
estimated population of 208 500.11,12 Nakaseke, which is located 
50 km from downtown Kampala and 14 km from the nearest 
highway, has been defined as rural by the Uganda Bureau of 
Statistics (Fig. 1).
Twenty-five enumeration areas each were selected for the 
urban and rural setting, with the probability of selection pro-
portional to the population size of the enumeration area, and 
1000 adults were randomly sampled in each setting. Fieldwork-
ers conducted home visits between November 2015 and June 
2016 to assess eligibility and obtain informed consent. Inclu-
sion criteria included: (i) age 35 years or older; (ii) full-time 
residency in either Kampala or Nakaseke; and (iii) capacity to 
consent to the study. Exclusion criteria included having active 
pulmonary tuberculosis or a current respiratory infection and 
pregnancy. The study was approved by the institutional review 
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Objective To determine the prevalence of chronic respiratory diseases in urban and rural Uganda and to identify risk factors for these diseases.
Methods The population-based, cross-sectional study included adults aged 35 years or older. All participants were evaluated by spirometry 
according to standard guidelines and completed questionnaires on respiratory symptoms, functional status and demographic characteristics. 
The presence of four chronic respiratory conditions was monitored: chronic obstructive pulmonary disease (COPD), asthma, chronic bronchitis 
and a restrictive spirometry pattern.
Findings In total, 1502 participants (average age: 46.9 years) had acceptable, reproducible spirometry results: 837 (56%) in rural Nakaseke 
and 665 (44%) in urban Kampala. Overall, 46.5% (698/1502) were male. The age-adjusted prevalence of any chronic respiratory condition 
was 20.2%. The age-adjusted prevalence of COPD was significantly greater in rural than urban participants (6.1 versus 1.5%, respectively; 
P < 0.001), whereas asthma was significantly more prevalent in urban participants: 9.7% versus 4.4% in rural participants (P < 0.001). The 
age-adjusted prevalence of chronic bronchitis was similar in rural and urban participants (3.5 versus 2.2%, respectively; P = 0.62), as was 
that of a restrictive spirometry pattern (10.9 versus 9.4%; P = 0.82). For COPD, the population attributable risk was 51.5% for rural residence, 
19.5% for tobacco smoking, 16.0% for a body mass index < 18.5 kg/m2 and 13.0% for a history of treatment for pulmonary tuberculosis.
Conclusion The prevalence of chronic respiratory disease was high in both rural and urban Uganda. Place of residence was the most 
important risk factor for COPD and asthma.
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boards of Mulago Hospital and the 
Uganda National Council of Science and 
Technology in Kampala, Uganda and 
the Johns Hopkins School of Medicine 
in Baltimore, United States of America.
Anthropometric measurements 
were taken in triplicate. Spirometry 
was carried out using an Easy on-PC 
spirometer (ndd, Zürich, Switzerland) 
and participants with low-quality results 
were asked to repeat the test on another 
day for up to three attempts.14 Those 
with evidence of pulmonary obstruc-
tion were tested again after administra-
tion of a bronchodilator (i.e. 400 µg of 
inhaled salbutamol). As there were no 
established reference parameters for 
lung function among Ugandans, we used 
the reference for African American in-
dividuals in the United States’ National 
Health and Nutrition Examination 
Survey.15 We defined pulmonary ob-
struction as a pre-bronchodilator ratio 
of forced expiratory volume in 1 second 
(FEV1) to forced vital capacity (FVC) 
below the lower limit of normal (i.e. a 
z-score ≤ −1.64).
We investigated four chronic respi-
ratory conditions: (i) COPD, defined as 
a post-bronchodilator FEV1/FVC ratio 
z-score ≤ −1.64;16 (ii) a restrictive spi-
rometry pattern, defined as a pre-bron-
chodilator FVC z-score ≤ −1.64 with a 
post-bronchodilator FEV1/FVC ratio 
z-score > −1.64;17 (iii) asthma, defined 
as a self-reported wheeze, use of asthma 
medication in the previous 12 months 
or a physician’s diagnosis of asthma;18 
and (iv) chronic bronchitis, defined as 
self-reported phlegm production for at 
least 3 months each year in two succes-
sive years.19 In addition, we examined 
airflow-limitation reversibility, defined 
as a post-bronchodilator increase in 
FEV1 of 12% or more from baseline 
or an increase in FVC of 200 mL or 
more.16 Respiratory symptoms and func-
tional status were evaluated using the St. 
George’s Respiratory Questionnaire, ver-
sion 1 of the 36-item short-form health 
survey (SF-36) and a modified BOLD 
(Burden of Obstructive Lung Disease) 
questionnaire,10,20,21 all adapted to the 
local language (i.e. Luganda).
Demographic questionnaires asked 
for details of biomass fuel smoke ex-
posure, human immunodeficiency 
virus (HIV) infection and history of 
treatment for pulmonary tuberculosis. 
Individuals in households that used 
wood or charcoal for cooking or heat-
ing were regarded as being exposed to 
biomass fuel smoke. Daily smoking was 
defined as self-reported smoking of one 
or more cigarettes per day, underweight, 
as a body mass index (BMI) < 18.5 kg/m2 
and obesity, as a BMI ≥ 30 kg/m2.
Biostatistical methods
Our primary aims were to determine 
how the age- and sex-adjusted preva-
lence of chronic respiratory diseases 
varied according to place of residence 
(i.e. urban or rural) and to estimate the 
fraction of chronic respiratory disease 
that could be attributed to urbaniza-
tion. Risk factors for chronic respira-
tory conditions were identified using 
single variable and multivariable logistic 
regression models; as risk factors, we in-
cluded sex, age, place of residence, daily 
smoking, use of biomass fuels, history of 
treatment for pulmonary tuberculosis, 
history of HIV infection and BMI. The 
adjusted odds ratios from these models 
were used to calculate attributable frac-
tions for different risk factors in our 
study population and represent the pro-
portional reduction in morbidity that 
would result if exposure to a particular 
risk factor were removed.22 Associa-
tions between these risk factors, FEV1, 
FVC and FEV1/FVC ratio z-scores were 
evaluated using multivariable linear 
regression models. In addition, multi-
variable logistic regression was used to 
analyse the association between revers-
ibility and these risk factors. For other 
analyses, a χ2 or Fisher’s exact test was 
used to compare proportions between 
groups and a t test, analysis of variance 
or Wilcoxon rank–sum test was used to 
compare continuous variables between 
subgroups, as appropriate. All analyses 
were carried out in R (The R Founda-
tion, Vienna, Austria) and we used 
the epitools package to perform direct 
standardization by age using population 
structure data for 2015 from the Uganda 
Bureau of Statistics.11,23,24
Results
Of the 2000 individuals originally 
identified for enrolment in the study, 
1772 met inclusion criteria, consented 
and agreed to undergo spirometry. 
Fig. 1. Kampala (urban) and Nakaseke (rural) enumeration areas, study of chronic respiratory disease, Uganda, 2015–2016
Kampala Nakaseke
Note: In each image, the highlighted area represents one of the 25 enumeration areas selected randomly in each setting with the probability of selection 
proportional to the population size of the enumeration area. Maps obtained from Google Earth version 9.0 (2017 Apr 8).13 Kampala, Uganda: 0°20’51”N, 32° 
35’15”E, Eye alt 1,176m. CNES/Airbus 2018. Nakaseke, Uganda: 0°41’59”N, 32° 24’42”E, Eye alt 1,176m. DigitalGlobe 2018.
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Ultimately, 84.8% (1502/1772) had 
acceptable and reproducible spirom-
etry results (Table 1): their average age 
was 46.9 years (standard deviation, 
SD: 10.6) and 46.5% (689/1502) were 
male. Self-reported biomass fuel smoke 
exposure was high in both rural and 
urban settings; in rural settings, 99.6% 
(832/837) of individuals reported using 
biomass fuels for cooking. The type of 
biomass fuel varied: 92.3% (771/837) of 
rural participants reported using wood, 
whereas 86.0% (564/665) of urban par-
ticipants reported using charcoal. We 
did not find any difference between the 
settings in self-reported history of HIV 
infection or treatment for pulmonary 
tuberculosis or in household size. How-
ever, a significantly greater percentage of 
participants in the urban setting had a 
secondary education (P < 0.001).
Prevalence and risk factors
The overall age- and sex-adjusted preva-
lence of the four chronic respiratory 
conditions studied was 20.2%: 20.8% 
in the rural and 19.4% in the urban set-
ting (P = 0.54). For COPD, the adjusted 
prevalence was 6.1% in rural partici-
pants versus 1.5% in urban participants 
(P < 0.001). In contrast, asthma was 
more prevalent in urban participants, 
in whom the adjusted prevalence was 
9.7% compared with 4.4% in rural 
Table 1. Study participants, chronic respiratory disease in rural and urban Uganda, 
2015–2016






Age in years, mean (SD) 49.1 (11.2) 44.1 (8.9) < 0.001
Male sex, no. (%) 380 (45.4) 318 (47.8) 0.40
Height in m, mean (SD) 1.60 (0.1) 1.62 (0.1) < 0.001
BMI, mean (SD) 24.0 (4.5) 25.9 (5.4) < 0.001
Secondary education, no. (%) 173 (21) 328 (50) < 0.001
Household size, median (IQR) 5 (3–7) 5 (3–7) 0.50
Biomass fuel smoke exposure, no. (%)
Daily biomass fuel use 832 (99.6) 614 (93.6) < 0.001
Fuel type
    Wood 771 (92.3) 50 (7.6) < 0.001
    Charcoal 61 (7.3) 564 (86.0) < 0.001
    Kerosene 1 (0.1) 22 (3.4) < 0.001
    Propane 0 (0.0) 12 (1.8) < 0.001
    Electricity 2 (0.2) 6 (0.9) 0.16
    Other 0 (0.0) 2 (0.3) 0.38
Daily tobacco smoking, no. (%) 66 (7.9) 65 (9.8) 0.20
Clinical history, no. (%)
Personal history of treatment for pulmonary 
tuberculosis
22 (3.0) 22 (3.6) 0.70
Personal history of hypertension 80 (9.8) 77 (13.3) 0.05
Personal history of diabetes 5 (0.7) 22 (4.5) < 0.001
Personal history of HIV infection 68 (8.1) 65 (9.8) 0.67
Family history of asthma or COPD 6 (1.0) 137 (33.6) < 0.001
BMI: body mass index; COPD: chronic obstructive pulmonary disease; HIV: human immunodeficiency virus; 
IQR: interquartile range; SD: standard deviation.
















Urban sample Rural sample










Crude prevalence Age- and sex -adjusted prevalence
95% CI
CI: confidence interval; COPD: chronic obstructive pulmonary disease.
Note: Age- and sex-adjusted values were calculated using mid-year estimates for 2015 from the Uganda Bureau of Statistics.
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participants (P < 0.001; Fig. 2). The ad-
justed prevalence of chronic bronchitis 
was similar in rural and urban partici-
pants (3.5% versus 2.2%, respectively; 
P = 0.62), as was that of a restrictive 
spirometry pattern (10.9% versus 9.4%, 
respectively; P = 0.82).
The most important factor as-
sociated with COPD was living in a 
rural environment, followed by daily 
smoking, a BMI < 18.5 kg/m2 and a 
history of treatment for pulmonary 
tuberculosis. Specifically, 51.5% (95% 
confidence interval, CI: 13.5–75.8) of 
the prevalence of COPD was attributable 
to living in a rural environment, 19.5% 
(95% CI: 3.1–45.2) was attributable to 
daily smoking, 16.0% (95% CI: 4.3–35.1) 
was attributable to a BMI < 18.5 kg/m2 
and 13.0% (95% CI: 3.5–30.8) was at-
tributable to a history of treatment for 
pulmonary tuberculosis (Fig. 3). For 
asthma, urban residence was the princi-
pal risk factor, with a PAR of 41.4% (95% 
CI: 14.2–63.1). The PAR of a history of 
treatment for pulmonary tuberculosis 
was 9.5% (95% CI: 0.8–29.8) for chronic 
bronchitis and 5.4% (95% CI: 0.2–16.4) 
for a restrictive spirometry pattern.
Symptoms and functional status
Although the reported rate of wheezing 
in the past 12 months was similar in 
urban and rural participants, the rate 
of asthma-related medication use and 
of a previous diagnosis of asthma were 
significantly higher in urban partici-
pants (Table 2). In addition, the reported 
number of days of work missed due to 
respiratory disease and the proportion 
of participants shortness of breath were 
both higher in the urban setting. There 
was no significant difference between 
the groups in respiratory symptoms, as 
assessed using the St. George’s Respira-
tory Questionnaire (Table 3). Partici-
pants from the urban setting reported 
fewer impairments in emotional well-
being than those from the rural setting: 
the mean SF-36 score was 57.2 and 77.3 
points, respectively (P = 0.001). There 
was no difference in physical function-
ing, social functioning, role limitation 
because of emotional problems, or over-
all health between the groups.
Lung function
In all participants, the mean ± SD pre-
bronchodilator FEV1, FVC and FEV1/
FVC ratio was 2.53 ± 0.66 L, 3.18 ± 0.75 L 
and 0.79 ± 0.08, respectively. Fig. 4 
presents the distribution of the pre-
bronchodilator FEV1/FVC ratio z-score, 
stratified by place of residence and sex. 
Both female and male participants in the 
rural setting had a lower FEV1/FVC ratio 
than their urban counterparts. Among 
participants found to have pulmonary 
obstruction on pre-bronchodilator 
Fig. 3. Risk factors for chronic respiratory conditions, Uganda, 2015–2016
Female sex
BMI  <18.5 kg/m2
BMI >30 kg/m2
Household with >5 people
Secondary education
Rural residence
History of treatment for 
pulmonary tuberculosis
History of HIV infection
Daily smoker
Decreased risk Decreased risk Decreased risk Decreased riskIncreased risk Increased risk Increased risk Increased risk
80 60 40 20 0 20 40 60 80 80 60 40 20 0 20 40 60 80 80 60 40 20 0 20 40 60 80 80 60 40 20 0 20 40 60 80
PAR
Estimated PAR 95% CI
BMI: body mass index; CI: confidence interval; COPD: chronic obstructive pulmonary disease; HIV: human immunodeficiency virus; PAR: population attributable risk.
Note: The four chronic respiratory conditions considered were chronic obstructive pulmonary disease (COPD), a restrictive spirometry pattern, asthma and chronic 
bronchitis.









No. (%) No. (%)
Asthma
Self-reported wheezing or whistling in the chest in 
the past 12 months
47 (5.6) 39 (5.9) 0.99
Self-reported medication use to aid breathing in 
the past 12 months
17 (2.0) 51 (7.7) < 0.001
Previous diagnosis of asthma 7 (0.8) 16 (2.4) 0.04
Chronic bronchitis  
Self-reported coughing up sputum for at least 
3 months in each of two successive years
27 (3.2) 16 (2.4) 0.41
Functional status
Self-reported experience of missing work due to, 
or having daily activities impeded by, respiratory 
problems in the past 12 months
7 (0.8) 26 (3.9) < 0.001
Self-reported shortness of breath on physical 
exertion
73 (8.7) 154 (23.2) < 0.001
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spirometry, the proportion with a post-
bronchodilator FEV1 less than 50% of 
predicted was higher in the rural than 
the urban setting: 18.9% (10/53) versus 
8.3% (1/12), respectively. However, the 
difference was not significant (P = 0.67). 
Fig. 5 shows the estimated effect of so-
ciodemographic and clinical variables 
on the pre-bronchodilator FEV1, FVC 
and FEV1/FVC ratio, as determined 
by multivariable regression analysis. 
A history of treatment for pulmonary 
tuberculosis was associated with a 
low adjusted pre-bronchodilator FEV1 
(p<0.001) FVC (P < 0.001) and FEV1/
FVC ratio (P < 0.001); living in a rural 
environment was associated with a low 
adjusted pre-bronchodilator FEV1 (P = 
0.009) and FEV1/FVC ratio (P < 0.001); 
and self-reported daily tobacco smok-
ing was associated with a low adjusted 
pre-bronchodilator FEV1/FVC ratio 
(P = 0.001). Among participants with 
obstruction, 26.2% (17/65) exhibited 
reversibility on post-bronchodilator 
spirometry – the proportion was 50.0% 
(6/12) in the urban setting and 20.8% 
(11/53) in the rural setting (P = 0.065).
Table 3. Disease severity and health-related quality of life, study participants with 
chronic obstructive pulmonary disease in rural and urban Uganda, 2015–2016




pants with COPDa 
(n = 12)
P
COPD severity,b no. (%) 0.04
Mild 20 (37.7) 3 (25.0) ND
Moderate 23 (43.4) 8 (66.7) ND
Severe 10 (18.9) 0 (0.0) ND
Very severe 0 (0.0) 1 (8.3) ND
St. George’s Respiratory Questionnaire score,20 mean (95% CI)
Symptoms domain 48.3 (40.5–56.1) 63.2 (51.6–74.8) 0.07
Activity domain 37.4 (26.8–48.0) 34.1 (17.8–50.5) 0.76
Psychosocial impact domain 27.4 (19.0–35.9) 32.0 (21.4–42.7) 0.59
Total 34.6 (25.5–43.6) 38.1 (27.4–48.7) 0.70
MRC dyspnoea scale score, median 
(IQR)
2 (1–2) 2 (2–2) 0.12
CI: confidence interval; COPD: chronic obstructive pulmonary disease; IQR: interquartile range; MRC: Medical 
Research Council; ND: not determined.
a  Chronic obstructive pulmonary disease (COPD) was defined as a post-bronchodilator ratio of forced 
expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) below the lower limit of normal (i.e. 
z-score ≤ 1.64) of the African American reference population in the United States’ National Health and 
Nutrition Examination Survey (NHANES).
b  COPD severity was defined by the GOLD criteria as mild (i.e. FEV1 ≥ 80% predicted), moderate (i.e. 
50% ≤ FEV1 < 80% predicted), severe (i.e. 30% ≤ FEV1 < 50% predicted) and very severe (FEV1 < 30% 
predicted).25





























Urban participants Urban participantsRural participants Rural participants
15 10 5 0 5 10 15 15 10 5 0 5 10 15





















FEV1: forced expiratory volume in 1 second; FVC: forced vital capacity.
Notes: The figure shows pre-bronchodilator FEV1/FVC ratio z-score distribution. Each bar represents a 0.2 increment in z-score. Bars that include the 5
th, 10th, 25th, 
50th, 75th, 90th or 95th percentile in each distribution are labelled accordingly. The z-scores were calculated using data for the African American reference population 
in the United States’ National Health and Nutrition Examination Survey (NHANES).
323Bull World Health Organ 2019;97:318–327| doi: http://dx.doi.org/10.2471/BLT.18.216523
Research
Urbanization and chronic respiratory disease, UgandaTrishul Siddharthan et al.
Discussion
Although previous studies in Uganda 
and sub-Saharan Africa have examined 
the prevalence of, and risk factors for, 
single respiratory diseases,8–10 few have 
examined the effect of urbanization on 
a range of chronic respiratory diseases 
and none has assessed the PAR. We 
found that one in every five adults in 
our study had a chronic respiratory 
condition and that place of residence 
was the single most important PAR 
factor. Specifically, 40% of people with 
asthma were attributable to urban resi-
dence and 50% of people with COPD 
were attributable to rural residence (a 
proxy for daily wood smoke exposure), 
which was a more important factor than 
tobacco smoking. Many participants in 
both urban and rural settings had a low 
lung volumes – this was associated with 
a history of treatment for pulmonary 
tuberculosis and being underweight, 
both of which are common in low- and 
middle-income countries.
Published data on the prevalence of 
chronic respiratory diseases in low- and 
middle-income countries cover a wide 
range. In the BOLD study, the preva-
lence of COPD in primarily urban envi-
ronments ranged from 11.4 to 23.8% and 
that of a restrictive spirometry pattern 
ranged from 4.2 to 48.7%.10,26 In Uganda, 
a FRESH AIR study found a COPD prev-
alence of 16.2% in a rural setting.8 The 
prevalence in our study was lower: 6.1% 
in rural and 1.5% in urban participants. 
There are several possible reasons for the 
varying estimates: (i) there may have 
been differences between the studies in 
the spirometry criteria used to diagnose 
COPD;27 (ii) the proportion of tobacco 
smokers was higher in the FRESH AIR 
study, which covered a tobacco-growing 
region, than in our study (36% versus 
9%, respectively) or in other parts of 
Uganda;8,28 and (iii) the average age 
of participants was lower in our study 
than in the BOLD study: 47 versus 
56 years, respectively.10 The difference 
in estimates is unlikely to have been 
due to differences in the proportion of 
participants with acceptable spirometry 
between our study (84.8%) and either 
BOLD (93%) or FRESH AIR (97%).8,10
The prevalence of chronic bron-
chitis in our study was 3.3%, which was 
similar to that in the BOLD study (i.e. 
3.1%) and in a population-based study 
in South Africa (i.e. 2.3 to 2.8%).29,30 
We found no difference between urban 
and rural settings, possibly because 
both ambient air pollution exposure in 
urban Kampala and household air pol-
lution exposure in rural Nakaseke were 
high.31 The prevalence of wheezing and 
of a physician’s diagnosis of asthma were 
similar in our study and in a population-
based study in sub-Saharan Africa.32 
Further, the overall prevalence of asthma 
was higher in our urban sample than 
our rural sample, which is consistent 
with findings in both high- and low-
income regions, including sub-Saharan 
Africa.33,34
Urban populations, particularly in 
low- and middle-income countries, are 
exposed to several risk factors that pre-
dispose to smaller lungs and accelerated 
lung function decline.35 Early life events, 
such as childhood respiratory infec-
tion,36 micronutrient deficiency and 
both ambient and household air pollu-
tion,37 can influence lung size and func-
tion, thereby predisposing individuals to 
obstructive pulmonary disease in adult-
hood.38 High cortisol and inflammatory 
biomarker levels due to urban stressors 
have been linked to lung injury.39 Expo-
sure to indoor and outdoor allergens, 
pollutants and irritants during the early 
years of life may tip a child’s immune 
system’s response from a non-asthma 
to an asthma phenotype, thereby lead-
ing to adult asthma. Diminished early 
exposure to parasites (exposure results 
in parasite-induced immunoglobulin-E) 
may lead to the development of atopic 
disease.40 Greater exposure to additives 
and synthetic foods may influence nu-
trition, which has been associated with 
asthma.35 A higher risk of communicable 
diseases such as tuberculosis and recur-
rent pulmonary infection can predispose 
to chronic respiratory diseases such as 
COPD, restrictive lung disease, asthma, 
chronic bronchitis and bronchiecta-
sis.30,34,41 Our findings reflect the effect of 
exposure to these risk factors on airway 
and parenchymal injury and disease and 
are consistent with previous data on the 
distribution of chronic respiratory dis-
ease in urban and rural environments in 
low- and middle-income countries.33,34,41
The leading risk factor for sev-
eral chronic respiratory diseases in 
both urban and rural settings remains 
chronic inflammation due to exposure 
to environmental substances. Although 
cigarette exposure is low in many Afri-
can countries, it is expected to rise with 
growing urbanization over the next two 
Fig. 5. Estimated effect of sociodemographic and clinical variables on lung function, Uganda, 2015–2016
Female  versus male sex
BMI  <18.5 kg/m2  versus normal
BMI >30 kg/m2  versus normal
Household with >5 people versus ≤ 5 people
Secondary education versus no secondary education
Rural versus  urban residence
History of treatment for pulmonary tuberculosis vs. not
History of HIV infection versus no history
Daily smoker versus non-smoker
Estimated mean difference in z-score
Estimated mean absolute differences in z-score 95% CI





 / FVC ratio
BMI: body mass index; CI: confidence interval; FEV1: forced expiratory volume in 1 second; FVC: forced vital capacity; HIV: human immunodeficiency virus.
Notes: Mean absolute differences in z-scores and corresponding 95% CI were obtained from multivariable regression analysis. A normal BMI was in the range 
20–25 kg/m2.
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decades, thereby increasing the preva-
lence of chronic respiratory disease.2 
Today, household air pollution remains 
the leading cause of COPD.28,42 In our 
study, biomass fuel was commonly used 
for cooking at both rural and urban sites 
though the type of fuel was different: 
the primary fuel was wood at rural sites 
and charcoal at urban sites. We were un-
able to assess differences in the relative 
risk of different types of fuel. However, 
burning wood emits more particulate 
matter than burning charcoal or lique-
fied petroleum gas and there have been 
reports that respiratory symptoms are 
more common in individuals in low- 
and middle-income countries who use 
wood than in those who use charcoal or 
liquefied petroleum gas.38
Our study has several strengths. 
First, it had a large population-based 
design and comprehensive spirometry 
and respiratory data were collected. Sec-
ond, we used the lower limit of normal 
for African American individuals in the 
National Health and Nutrition Examina-
tion Survey to identify COPD and a re-
strictive spirometry pattern, this helped 
prevent overdiagnosis of obstruction 
and restriction, particularly in elderly 
people.27 Third, by calculating PARs, we 
were able to gain a better understanding 
of the risk factors for chronic respira-
tory diseases. Our study also has some 
potential shortcomings. First, we were 
unable to recruit 15.2% (270/1772) of 
individuals who met inclusion criteria 
after two follow-up visits; nevertheless, 
our non-response rate was lower than 
in many other studies. Second, partici-
pants who had incomplete spirometry 
results were predominantly elderly or 
had severe respiratory disease, which 
highlights the difficulty of spirometry 
in those with reduced pulmonary func-
tion. The disease burden may therefore, 
have been underestimated. Third, 
urban participants were younger than 
rural participants, which may have af-
fected the crude disease prevalence; 
however, we calculated age- and sex-
adjusted prevalences to reduce the risk 
of bias. Fourth, we defined asthma as 
a self-reported wheeze, use of asthma 
medications or a physician’s diagnosis. 
The last two criteria are closely linked 
to health-care access and utilization, 
which may be influenced by socioeco-
nomic status. Consequently, the higher 
rates we observed for these two criteria 
among urban participants may reflect 
better access to health care. However, 
post-bronchodilator reversibility, which 
indicates greater airway reactivity, was 
significantly more common in urban 
residents with obstruction. Fifth, we 
did not assess individual exposure to 
air pollution. Better understanding of 
the association between urbanization 
and chronic respiratory disease requires 
longitudinal assessment of individual 
exposure to air pollution.
The increase in urbanization over 
the next two decades is expected to 
occur almost exclusively in low- and 
middle-income countries and, by 2030, 
half of sub-Saharan Africa’s population 
will reside in an urban area.7 However, 
poor infrastructure and a lack of policy 
interventions aimed at sustainable urban 
growth will have severe health impli-
cations for many people in low- and 
middle-income countries worldwide. 
Future public health interventions will 
depend on a good understanding of 
the evolving disease burden. Currently, 
chronic respiratory disease is associated 
with chronic inflammation throughout 
life, whether due to household air pollu-
tion, the urban microenvironment (e.g. 
allergens and outdoor air pollution) or 
recurrent pulmonary infection.40 As 
urban dwellers transition to cleaner 
fuels for cooking and heating, cigarette 
exposure and outdoor air pollution will 
become increasingly important risk 
factors.
In summary, we found a high bur-
den of chronic respiratory disease in 
both rural and urban Uganda. Place of 
residence was the single most important 
risk factor: urban residence was the 
principal risk factor for asthma and rural 
residence was the principal risk factor 
for COPD. As urbanization continues 
in sub-Saharan Africa, the profile and 
burden of chronic respiratory disease 
are likely to change in parallel. ■
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صخلم
ادنغوأ في ةيفيرلاو ةيضرلحا قطانلما في ةنمزلما سيفنتلا زاهلجا ضارمأ راشتنا
 قطانلما في ةنمزلما سيفنتلا زاهلجا ضارمأ راشتنا ىدم ديدتح ضرغلا
.ضارملأا هذله رطلخا لماوع ديدتحو ،ادنغوأ في ةيفيرلاو ةيضرلحا
 نمم  رابكلا  تلمش  ةددعتم  ةيناكس  تاعاطقل  ةسارد  ةقيرطلا
 سايق قيرط نع ينكراشلما عيجم مييقت مت .بركأ وأ ًاماع 35 نوغلبي
 ةلمتكلما  تانايبتسلااو  ةيسايقلا  ةيهيجوتلا  ئدابملل  اقفو  سفنتلا
 صئاصلخاو  ،ةيفيظولا  ةلالحاو  ،سيفنتلا  زاهلجا  ضارعأ  لىع
 ضرم :ةنمزم ةيسفنت تلااح عبرأ دوجو دصر مت .ةيفارغوميدلا
 بعشلا  باهتلاو  ،وبرلاو  ،(COPD)  نمزلما  يوئرلا  دادسنلاا
.ديقلما سفنتلا سايق طمنو ،نمزلما ةيئاولها
 46.9  :رمعلا  طسوتم)  اًكراشم  1502  ىدل  ناك  ،ًلااجمإ  جئاتنلا
 ةقطنم في (56٪) 837 :ةرركتمو ةلوبقم سفنت سايق جئاتن (اًماع
 ،امومعو  .ةيضرلحا  لاابماك  في  (44٪)  665و  ةيفيرلا  يكيساكان
 يأ  راشتنا  لدعم  ناك  .روكذلا  نم  (1502/698)  46.5٪  ناك
 لدعم  ناك  .20.2٪  وه  رمعلاب  ةلص  تاذ  ةنمزم  ةيسفنت  ةلاح
 يرثكب بركأ رمعلاب ةلصلا يذ نمزلما يوئرلا دادسنلاا ضرم راشتنا
 6.1٪)  ةيضرلحا  قطانلما  في  هنع  ةيفيرلا  قطانلما  نم  ينكراشلما  في
 ينح  في  ،(0.001  >  لماتحلاا  ةبسن  ؛لياوتلا  لىع  ،1.5٪  لباقم
 قطانلما  نم  ينكراشلما  في  يربك  لكشب  ًاعويش  رثكأ  ناك  وبرلا  نأ
 ةيفيرلا  قطانلما  نم  ينكراشلما  في  4.4٪  لباقم  9.7٪  :ةيضرلحا
 بعشلا  باهتلا  راشتنا  لدعم  ناك  .(0.001  >  لماتحلاا  ةبسن)
 قطانلما  نم  ينكراشلما  في  ًابهاشم  رمعلاب  ةلصلا  يذ  نمزلما  ةيئاولها
 ةبسن ؛لياوتلا لىع ،2.2٪ لباقم 3.5٪) ةيضرلحا قطانلماو ةيفيرلا
 ديقلما سفنتلا سايق طمن في لالحا ناك كلذكو ،(0.62 = لماتحلاا
 ضرلم ةبسنلاب .(0.82 =  لماتحلاا ةبسن ؛9.4٪  لباقم 10.9٪)
 51.5٪ وه ناكسلل بوسنلما رطلخا ناك ،نمزلما يوئرلا دادسنلاا
 شرؤلم 16.0٪و ،غبتلا ينخدتل 19.5٪و ،ةيفير قطانم في ةماقلإل
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结果 共有 1502 名参与者（平均年龄 ：46.9 岁）有
可接受和可重复的肺活量测定结果 ：837 名 (56%) 来




（分别为 6.1% 和 1.5% ；P < 0.001），然而哮喘的年龄标
化患病率在城市更高 ：分别为城市参与者 9.7% 和农
村参与者 4.4% （P < 0.001）。农村和城市参与者的慢性
支气管炎年龄标化患病率相近（分别为 3.5% 和 2.2% ；
P = 0.62），限制性通气功能障碍年龄标化患病率亦是
相近（分别为 10.9% 和 9.4% ；P = 0.82）。对于慢性阻
塞性肺病而言，城市居民的人群归因危险度为 51.5%，






Prévalence de maladies respiratoires chroniques en zones urbaines et rurales en Ouganda
Objectif Déterminer la prévalence de maladies respiratoires chroniques 
en zones urbaines et rurales en Ouganda et identifier les facteurs de 
risque associés à ces maladies.
Méthodes L'étude de prévalence basée sur une population incluait 
des adultes âgés de 35 ans ou plus. Tous les participants ont été soumis 
à un test de spirométrie conformément aux directives standards 
et ont rempli un questionnaire sur leurs symptômes respiratoires, 
leur état fonctionnel et leurs caractéristiques démographiques. La 
présence de quatre maladies respiratoires chroniques a été contrôlée: 
bronchopneumopathie chronique obstructive, asthme, bronchite 
chronique et modèle de spirométrie restrictive.
Résultats Au total, 1502 individus (âge moyen: 46,9 ans) ont obtenu 
des résultats de spirométrie acceptables, reproductibles: 837 (56%) à 
Nakaseke, en zone rurale, et 665 (44%) à Kampala, en zone urbaine. 
Dans l'ensemble, 46,5% (698/1502) étaient des hommes. La prévalence 
ajustée selon l'âge de toutes les maladies respiratoires chroniques était 
de 20,2%. La prévalence ajustée selon l'âge de la bronchopneumopathie 
chronique obstructive était considérablement plus élevée chez les 
participants ruraux que chez les participants urbains (6,1 contre 1,5%, 
respectivement; P < 0,001), tandis que la prévalence de l'asthme était 
considérablement plus élevée chez les participants urbains: 9,7% contre 
4,4% pour les participants ruraux (P < 0,001). La prévalence ajustée 
selon l'âge de la bronchite chronique était similaire chez les participants 
ruraux et urbains (3,5 contre 2,2%, respectivement; P = 0,62), de même 
que la prévalence d'un modèle de spirométrie restrictive (10,9 contre 
9,4%; P = 0,82). Dans le cas de la bronchopneumopathie chronique 
obstructive, la fraction étiologique du risque était de 51,5% pour le lieu 
de résidence rural, 19,5% pour l'usage du tabac, 16,0% pour un indice de 
masse corporel < 18,5 kg/m2 et 13,0% pour un antécédent de traitement 
de la tuberculose pulmonaire.
Conclusion La prévalence de maladies respiratoires chroniques était 
élevée à la fois en zone rurale et en zone urbaine en Ouganda. Le 
lieu de résidence était le facteur de risque le plus important pour la 
bronchopneumopathie chronique obstructive et l'asthme. 
Резюме
Распространенность хронических респираторных заболеваний в сельских и городских районах Уганды
Цель  Определить распространенность хронических 
респираторных заболеваний в сельских и городских районах 
Уганды и выявить факторы риска для этих заболеваний.
Методы  Проводилось популяционное перекрестное 
исследование среди взрослого населения в возрасте от 35 лет. 
Все участники оценивались посредством спирометрии в 
соответствии со стандартными рекомендациями. Они заполняли 
анкеты о респираторных симптомах, своем функциональном 
состоянии и указывали демографические характеристики. 
Отслеживалось наличие четырех хронических респираторных 
заболеваний: хронической обструктивной болезни легких (ХОБЛ), 
астмы, хронического бронхита и рестриктивных нарушений.
Результаты Всего было обследовано 1502 участника (средний 
возраст составил 46,9 года), которые продемонстрировали 
приемлемые и воспроизводимые результаты спирометрии: 
837 (56%) в сельском районе Накасеке и 665 (44%) в городском 
районе Кампала. Из них 46,5% (698 из 1502 человек) составляли 
мужчины. Распространенность любого из исследуемых 
хронических респираторных заболеваний с учетом поправки 
на возраст составила 20,2%. Распространенность ХОБЛ 
с учетом поправки на возраст была значительно выше в 
сельской местности, чем среди участников-горожан (6,1 и 1,5% 
соответственно, P < 0,001), тогда как астма намного заметнее 
преобладала среди горожан: 9,7 против 4,4% в сельской 
местности (P < 0,001). Распространенность хронического 
бронхита с поправкой на возраст почти не отличалась в сельской 
и городской местности (3,5 и 2,2% соответственно, P = 0,62), то же 
самое наблюдалось и для рестриктивных нарушений (10,9 и 9,4%, 
 خيرات  دوجول 13.0٪و ،2م/مجك 18.5  نم بركلأا مسلجا ةلتك
.يوئرلا لسلا جلاعل قباس
 في  ًاعفترم  ةنمزلما  ةيسفنتلا  ضارملأا  راشتنا  لدعم  ناك  جاتنتسلاا
 لماع مهأ ةماقلإا ناكم ناك .ادنغوأب ةيضرلحاو ةيفيرلا قطانلما لك
.وبرلاو نمزلما يوئرلا دادسنلاا ضرلم رطخ
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P = 0,82). Популяционный риск, приписываемый фактору ХОБЛ, 
составлял 51,5% для проживающих в сельской местности, 19,5% 
для курящих табак, 16,0% для участников с ИМТ менее 18,5 кг/м2 
и 13,0% для участников с перенесенным туберкулезом легких в 
анамнезе.
Вывод Распространенность хронических респираторных 
заболеваний и в сельской и в городской местности Уганды 
оказалась высокой. Наиболее существенным фактором риска 
для ХОБЛ и астмы оказалось место проживания.
Resumen
Prevalencia de enfermedades respiratorias crónicas en zonas urbanas y rurales de Uganda
Objetivo Determinar la prevalencia de las enfermedades respiratorias 
crónicas en las zonas urbanas y rurales de Uganda e identificar los 
factores de riesgo de estas.
Métodos El estudio transversal basado en la población incluyó adultos 
de 35 años o más. Todos los participantes se evaluaron por espirometría 
de acuerdo con las directrices estándar y completaron cuestionarios 
sobre los síntomas respiratorios, el estado funcional y las características 
demográficas. Se monitorizó la presencia de cuatro afecciones 
respiratorias crónicas: enfermedad pulmonar obstructiva crónica (EPOC), 
asma, bronquitis crónica y un patrón de espirometría restrictivo.
Resultados En total, 1502 participantes (edad media: 46,9 años) tuvieron 
unos resultados de espirometría aceptables y reproducibles: 837 (56 %) 
en la zona rural de Nakaseke y 665 (44 %) en la zona urbana de Kampala. 
En total, el 46,5 % (698/1502) eran hombres. La prevalencia ajustada 
por edad de cualquier afección respiratoria crónica fue de 20,2 %. La 
prevalencia de la EPOC ajustada por edad fue significativamente mayor 
en los participantes rurales que en los urbanos (6,1 frente a 1,5 %, 
respectivamente; p < 0,001), mientras que el asma fue significativamente 
más frecuente en los participantes urbanos: 9,7 % frente a 4,4 % en los 
participantes rurales (p < 0,001). La prevalencia ajustada por edad de la 
bronquitis crónica fue similar en los participantes rurales y urbanos (3,5 % 
frente a 2,2 %, respectivamente; p = 0,62), al igual que la de un patrón 
espirométrico restrictivo (10,9 % frente a 9,4 %; p = 0,82). Para la EPOC, 
el riesgo atribuible a la población fue del 51,5 % para la residencia rural, 
del 19,5 % para el tabaco, del 16,0 % para un índice de masa corporal 
inferior a 18,5 kg/m2 y del 13,0 % para un historial de tratamiento de la 
tuberculosis pulmonar.
Conclusión La prevalencia de las enfermedades respiratorias crónicas 
era alta tanto en las zonas rurales como en las urbanas de Uganda. El 
lugar de residencia fue el factor de riesgo más importante para la EPOC 
y el asma.
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